A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin
about
Endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of solid pancreaticobiliary lesions: Clinical aspects to improve the diagnosisDiagnostic endoscopic ultrasonography: assessment of safety and prevention of complicationsBasic techniques in endoscopic ultrasound-guided fine needle aspiration for solid lesions: Adverse events and avoiding them.Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelinesPrevention of gastrointestinal events in patients on antithrombotic therapy in the peri-endoscopy period: review of new evidence and recommendations from recent guidelines.Endoscopic ultrasonography-guided tissue acquisition: How to achieve excellence.Patterns of antiplatelet agent use in the US.3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.Clinical use of endoscopic ultrasound-guided fine-needle aspiration: Guidelines and recommendations from Chinese Society of Digestive Endoscopy.Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines.A Prospective Multicenter Study Evaluating Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Prescribed Antithrombotic Agents.Endoscopic ultrasound-guided fine-needle aspiration of solid lesions on clopidogrel may not be a high-risk procedure for bleeding: A case series.The Bleeding Risk after Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients Taking Antithrombotic Agents Is Not Negligible.
P2860
Q26774673-F25AA1C1-DE10-4CEC-94DF-0BCB3F0D21B7Q30463472-1EC77DAB-7E42-43BF-814F-448CDB856DE7Q33776873-C7F5CBD8-92C1-40F7-9028-463EAA162E9EQ36682317-9566DC6B-2526-4480-9C5C-96F1B029EB1DQ38394833-FF1F6780-256B-4A21-94AB-DA99C4E44C39Q39111507-DE7F58E8-3E19-4D5F-AAA3-E6F38A1C8AA8Q41585393-CAC976E5-31BC-4C74-8176-6EA2D84F3D12Q42134079-82AA1636-A1A9-4C3F-B373-AB1B80D69587Q42289481-FA747EA8-02CA-4070-B026-888B7644BF01Q48248862-B420039F-C263-423A-9C15-2E4799D6B9B7Q50148733-D8DC99AC-3D3F-43F0-B7FC-1B4319C0B103Q53301896-D484727B-92FE-4E49-8DDE-B27B1E414673Q55227374-31C7F50C-7039-44D7-940B-D4DF622EA4A2
P2860
A prospective control study of the safety and cellular yield of EUS-guided FNA or Trucut biopsy in patients taking aspirin, nonsteroidal anti-inflammatory drugs, or prophylactic low molecular weight heparin
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A prospective control study of ...... c low molecular weight heparin
@ast
A prospective control study of ...... c low molecular weight heparin
@en
A prospective control study of ...... c low molecular weight heparin
@nl
type
label
A prospective control study of ...... c low molecular weight heparin
@ast
A prospective control study of ...... c low molecular weight heparin
@en
A prospective control study of ...... c low molecular weight heparin
@nl
prefLabel
A prospective control study of ...... c low molecular weight heparin
@ast
A prospective control study of ...... c low molecular weight heparin
@en
A prospective control study of ...... c low molecular weight heparin
@nl
P2093
P921
P1476
A prospective control study of ...... c low molecular weight heparin
@en
P2093
Charles Kien-Fong Vu
John Meenan
Laura Doig
P304
P356
10.1016/J.GIE.2005.09.033
P407
P50
P577
2006-05-01T00:00:00Z